COYA: Coya Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 128.21
Enterprise Value ($M) 95.58
Book Value ($M) 35.64
Book Value / Share 2.44
Price / Book 3.60
NCAV ($M) 35.57
NCAV / Share 2.44
Price / NCAV 3.60

Profitability (mra)
Return on Invested Capital (ROIC) -0.22
Return on Assets (ROA) -0.46
Return on Equity (ROE) -0.49

Liquidity (mrq)
Quick Ratio 8.15
Current Ratio 8.15

Balance Sheet (mrq) ($M)
Current Assets 41.20
Assets 41.26
Liabilities 5.63
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6.00
Operating Income -7.36
Net Income -7.99

Cash Flow Statement (mra) ($M)
Cash From Operations -11.19
Cash from Investing -0.54
Cash from Financing 38.43

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Greenlight Capital Inc 8.80 -0.39
02-07 13G/A Hirschman Orin 8.10 68.17

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 4,770 39,361 12.12
2024-05-02 5,672 11,602 48.89
2024-05-01 8,520 9,471 89.96
2024-04-30 11,761 11,628 101.14
2024-04-29 5,878 3,374 174.21

(click for more detail)

Similar Companies
COCP – Cocrystal Pharma, Inc. COEP – Coeptis Therapeutics Holdings, Inc.
CORT – Corcept Therapeutics Incorporated CPRX – Catalyst Pharmaceuticals, Inc.
CRBP – Corbus Pharmaceuticals Holdings, Inc.


Financial data and stock pages provided by
Fintel.io